Implementation of an Oral Antineoplastic Therapy Program: Results From a Pilot Project.
Clin J Oncol Nurs
; 26(1): 61-70, 2022 02 01.
Article
em En
| MEDLINE
| ID: mdl-35073288
ABSTRACT
BACKGROUND:
The Oncology Care Model requires implementation of processes to reduce urgent care (UC), emergency department (ED), and hospital visits for patients on antineoplastic therapies, including oral antineoplastic agents.OBJECTIVES:
The purpose of this project was to develop, implement, and initially evaluate an oral antineoplastic therapy program (OAP) and an oncology antineoplastic nurse navigator (OANN) role aimed at reducing UC, ED, and hospital visits.METHODS:
This pilot project used a descriptive correlational design to analyze the impact of the novel role of the OANN on UC, ED, and hospital visits.FINDINGS:
The OANN engaged 1,095 patients between January 1, 2019, and December 31, 2020. A reduction in UC, ED, and hospital visits was noted between 2019 and 2020 for patients followed by the OANN and enrolled in the OAP. Patients who were contacted by the OANN three or more times after starting their oral antineoplastic agent were less likely to be seen in UC or the ED or to be hospitalized. The novel role of the OANN within the overall OAP provided a significant benefit in reducing UC and ED visits and hospitalization for patients enrolled in the program.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Prevencao_e_fatores_de_risco
/
Agentes_cancerigenos
Base de dados:
MEDLINE
Assunto principal:
Assistência Ambulatorial
/
Antineoplásicos
Tipo de estudo:
Prognostic_studies
/
Sysrev_observational_studies
Limite:
Humans
Idioma:
En
Revista:
Clin J Oncol Nurs
Assunto da revista:
ENFERMAGEM
/
NEOPLASIAS
Ano de publicação:
2022
Tipo de documento:
Article